Table 2

Risk of relapse of distal ulcerative colitis in the patients receiving three suppositories a week of either 1 g mesalazine or placebo

Time interval (days) Mesalazine No (%) Placebo No (%) p Value
0–909/45  (19)18/46 (38)0.035
0–18013/45 (29)25/46 (54)0.017
0–27017/45 (38)28/46 (60)0.031
0–36522/45 (48)29/46 (62)0.18